State Street’s Esperion Therapeutics ESPR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$19.3M Buy
7,055,794
+1,125,498
+19% +$3.56M ﹤0.01% 2251
2025
Q4
$21.9M Buy
5,930,296
+1,451,462
+32% +$4.69M ﹤0.01% 2217
2025
Q3
$11.9M Buy
4,478,834
+720,112
+19% +$1.39M ﹤0.01% 2546
2025
Q2
$3.7M Sell
3,758,722
-789,526
-17% -$791K ﹤0.01% 3067
2025
Q1
$6.55M Buy
4,548,248
+44,014
+1% +$81.1K ﹤0.01% 2762
2024
Q4
$9.91M Buy
4,504,234
+649,920
+17% +$1.52M ﹤0.01% 2635
2024
Q3
$6.36M Buy
3,854,314
+99,802
+3% +$202K ﹤0.01% 2844
2024
Q2
$8.34M Buy
3,754,512
+3,203,263
+581% +$7.54M ﹤0.01% 2666
2024
Q1
$1.48M Buy
551,249
+167,500
+44% +$407K ﹤0.01% 3374
2023
Q4
$1.15M Buy
383,749
+81,300
+27% +$105K ﹤0.01% 3455
2023
Q3
$296K Hold
302,449
﹤0.01% 3822
2023
Q2
$420K Sell
302,449
-1,600,965
-84% -$2.24M ﹤0.01% 3734
2023
Q1
$3.03M Buy
1,903,414
+149,105
+8% +$770K ﹤0.01% 3174
2022
Q4
$10.9M Buy
1,754,309
+221,161
+14% +$1.58M ﹤0.01% 2640
2022
Q3
$10.3M Buy
1,533,148
+288,609
+23% +$1.98M ﹤0.01% 2697
2022
Q2
$7.92M Buy
1,244,539
+328,101
+36% +$1.86M ﹤0.01% 2861
2022
Q1
$4.25M Sell
916,438
-129,939
-12% -$557K ﹤0.01% 3264
2021
Q4
$5.23M Buy
1,046,377
+469,096
+81% +$3.76M ﹤0.01% 3218
2021
Q3
$6.96M Sell
577,281
-1,674,913
-74% -$24.4M ﹤0.01% 3067
2021
Q2
$47.6M Buy
2,252,194
+133,748
+6% +$3.22M ﹤0.01% 1881
2021
Q1
$59.4M Sell
2,118,446
-404,098
-16% -$11.9M ﹤0.01% 1612
2020
Q4
$65.6M Buy
2,522,544
+719,794
+40% +$21.6M ﹤0.01% 1466
2020
Q3
$67M Buy
1,802,750
+55,054
+3% +$2.18M ﹤0.01% 1238
2020
Q2
$89.7M Buy
1,747,696
+641,079
+58% +$26.8M 0.01% 1036
2020
Q1
$34.9M Buy
1,106,617
+5,108
+0.5% +$270K ﹤0.01% 1489
2019
Q4
$65.7M Sell
1,101,509
-340,851
-24% -$15.3M ﹤0.01% 1338
2019
Q3
$52.9M Sell
1,442,360
-150,621
-9% -$5.97M ﹤0.01% 1406
2019
Q2
$74.1M Buy
1,592,981
+204,891
+15% +$9.62M 0.01% 1231
2019
Q1
$55.7M Sell
1,388,090
-119,159
-8% -$5.35M ﹤0.01% 1382
2018
Q4
$69.3M Sell
1,507,249
-338,559
-18% -$16.3M 0.01% 1136
2018
Q3
$81.9M Sell
1,845,808
-327,929
-15% -$15.1M 0.01% 1211
2018
Q2
$85.2M Buy
2,173,737
+859,024
+65% +$43.4M 0.01% 1144
2018
Q1
$95.1M Buy
1,314,713
+145,881
+12% +$10.7M 0.01% 1037
2017
Q4
$77M Sell
1,168,832
-91,582
-7% -$4.93M 0.01% 1171
2017
Q3
$63.2M Sell
1,260,414
-246,100
-16% -$11.9M 0.01% 1239
2017
Q2
$69.7M Buy
1,506,514
+1,093,292
+265% +$40.2M 0.01% 1152
2017
Q1
$14.6M Buy
413,222
+174,740
+73% +$4M ﹤0.01% 2157
2016
Q4
$2.99M Sell
238,482
-5,264
-2% -$62.7K ﹤0.01% 2939
2016
Q3
$3.38M Sell
243,746
-2,525
-1% -$28.6K ﹤0.01% 2768
2016
Q2
$2.44M Sell
246,271
-2,557
-1% -$42.4K ﹤0.01% 2949
2016
Q1
$4.21M Sell
248,828
-828,638
-77% -$13.3M ﹤0.01% 2643
2015
Q4
$24M Buy
1,077,466
+349,589
+48% +$8.82M ﹤0.01% 1591
2015
Q3
$17.2M Buy
727,877
+205,457
+39% +$12.9M ﹤0.01% 1852
2015
Q2
$42.7M Buy
522,420
+129,572
+33% +$12.7M ﹤0.01% 1363
2015
Q1
$36.4M Buy
392,848
+316,922
+417% +$20.5M ﹤0.01% 1427
2014
Q4
$3.07M Buy
75,926
+27,872
+58% +$853K ﹤0.01% 2838
2014
Q3
$1.18M Buy
48,054
+6,451
+16% +$103K ﹤0.01% 3206
2014
Q2
$660K Buy
41,603
+1,560
+4% +$22.5K ﹤0.01% 3303
2014
Q1
$608K Buy
40,043
+2,510
+7% +$39K ﹤0.01% 3337
2013
Q4
$516K Buy
37,533
+7,333
+24% +$107K ﹤0.01% 3356
2013
Q3
$569K Buy
+30,200
New +$507K ﹤0.01% 3333

Other funds holding ESPR